S.R. David

2.3k citations

28 papers · 1.8k indexed · h-index 10

Impact in

Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
Clinical Psychology top 5%
- Healthcare Decision-Making and Restraints
- Psychiatric care and mental health services

Papers in ⓘ

Psychiatry and Mental health 20
- Schizophrenia research and treatment 14
- Electroconvulsive Therapy Studies 10
- Bipolar Disorder and Treatment 9
- Epilepsy research and treatment 3
Clinical Psychology 8
- Healthcare Decision-Making and Restraints 7
- Psychiatric care and mental health services 2

Co-authors: Craig Mallinckrodt (3 shared papers)W. Scott Clark (2 shared papers)Alan Breier (11 shared papers)Cindy C. Taylor (7 shared papers)Karena Meehan (11 shared papers)Mauricio Tohen (5 shared papers)Bruce J. Kinon (1 shared paper)Pádraig Wright (5 shared papers)
Journals: European Neuropsychopharmacology (11 papers)Schizophrenia Research (5 papers)European Psychiatry (3 papers)American Journal of Psychiatry (2 papers)Mathematical and Computer Modelling (1 paper)
Partner nations: United States United Kingdom South Africa

In The Last Decade

S.R. David

26 papers receiving 1.6k citations

Peers

Replace Mingyuan Zhang with:

Mingyuan Zhang China

Virginia K. Sutton United States

Steven J. Romano United States

Rainer Schaub Germany

S Martin United Kingdom

Arja Tuunainen Finland

Martin Birkett United States

W. W. Fleischhacker Austria

Rosa Ayesa‐Arriola Spain

Theresa Wimberley Denmark

S.R. David relative to Mingyuan Zhang China Mingyuan Zhang's profile →

Citations per field

00.5×2×4×6×7.3×

Mingyuan Zhang · 1×

×1.5 1k/820

PMH

×1.6 560/359

CP

×1.1 48/43

BP

×7.3 145/20

SP

×1.7 196/118

PHARM

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by S.R. David

Since Specialization

Citations

This map shows the geographic impact of S.R. David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.R. David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.R. David more than expected).

Fields of papers citing papers by S.R. David

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.R. David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.R. David. The network helps show where S.R. David may publish in the future.

Co-authors

The 25 scholars most cited alongside S.R. David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S.R. David Line = papers co-authored together S.R. David links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Olanzapine Versus Placebo in the Treatment of Acute Mania American Journal of Psychiatry ·Mauricio Tohen, T.M. Sanger, Susan L. McElroy, Gary D. Tollefson, K. N. Roy Chengappa, David G. Daniel, Frederick Petty, Franca Centorrino, Richard Wang, Starr L. Grundy, Michael G. Greaney, T. Jacobs, S.R. David, V. Toma, The Olanzapine HGEH Study Group	1999	443
2	ACCOUNTING FOR DROPOUT BIAS USING MIXED-EFFECTS MODELS Journal of Biopharmaceutical Statistics ·Craig Mallinckrodt, W. Scott Clark, S.R. David	2001	312
3	Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia American Journal of Psychiatry ·Pádraig Wright, Martin Birkett, S.R. David, Karena Meehan, Iris Ferchland, Karla Alaka, J. C. Saunders, J Krueger, Philip Bradley, Luis San, Miquel Bernardo, Michael J. Reinstein, Alan Breier	2001	218
4	A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia Archives of General Psychiatry ·Alan Breier, Karena Meehan, Martin Birkett, S.R. David, Iris Ferchland, Virginia K. Sutton, Cindy C. Taylor, R. Palmer, Martín Dossenbach, Geri Kiesler, S. Brook, Pádraig Wright	2002	207
5	The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia Clinical Therapeutics ·S.R. David, Cindy C. Taylor, Bruce J. Kinon, Alan Breier	2000	182
6	A Double-Blind, Randomized Comparison of the Efficacy and Safety of Intramuscular Injections of Olanzapine, Lorazepam, or Placebo in Treating Acutely Agitated Patients Diagnosed With Bipolar Mania Journal of Clinical Psychopharmacology ·Karena Meehan, Fan Zhang, S.R. David, Mauricio Tohen, Philip G. Janicak, Joyce G. Small, Kimberly Koch, Rosemary T. Rizk, Daniel Walker, P. Tran, Alan Breier	2001	171
7	Type I Error Rates from Mixed Effects Model Repeated Measures Versus Fixed Effects Anova with Missing Values Imputed Via Last Observation Carried Forward Drug Information Journal ·Craig Mallinckrodt, W. Scott Clark, S.R. David	2001	119
8	Olanzapine vs. placebo in rapid-cycling bipolar disorder Schizophrenia Research ·T.M. Sanger, M. Tohen, G.D. Tollefson, T. Jacobs, S.R. David	1998	13
9	Treatment of negative symptoms with olanzapine in comparison with other novel antipsychotic agents European Neuropsychopharmacology ·S.R. David, Karena Meehan, Virginia K. Sutton, Cindy C. Taylor	1999	12
10	A double-blind study of intramuscular olanzapine, haloperidol and placebo in acutely agitated schizophrenic patients European Neuropsychopharmacology ·Pádraig Wright, Martin Birkett, Iris Ferchland, Paula R. Pullen, S.R. David, Karla Alaka, S. Brook, Michael J. Reinstein, Alan Breier	2000	9
11	Prolactin levels in olanzapine versus typical and atypical antipsychotics European Neuropsychopharmacology ·S.R. David, A.M. Crawford, Alan Breier	1998	8
12	Prolactin levels in olanzapine versus typical and atypical antipsychotics Schizophrenia Research ·S.R. David, A.M. Crawford, Alan Breier	1998	8
13	Olanzapine versus placebo in the treatment of acute mania European Neuropsychopharmacology ·Mauricio Tohen, T.M. Sanger, Sharon McElroy, Gary D. Tollefson, Starr L. Grundy, M G Greaney, T. Jacobs, S.R. David, Scott W. Andersen, V. Toma	1998	7
14	Calming versus sedative effects of IM olanzapine in agitated patients European Psychiatry ·S.R. David, John Battaglia, K.L. Alaka, Karena Meehan, Pádraig Wright	2002	7
15	Treatment of negative symptoms with olanzapine in comparison with other novel antipsychotic agents Schizophrenia Research ·S.R. David, Karena Meehan, Virginia K. Sutton, Cindy C. Taylor	2000	6
16	Change in extrapyramidal symptoms with olanzapine in comparison with other antipsychotic agents Schizophrenia Research ·Karena Meehan, S.R. David, Cindy C. Taylor, Virginia K. Sutton	2000	6
17	Hierarchical Bayesian analysis of the carryover effect in two-period crossover designs Mathematical and Computer Modelling ·S.R. David, John W. Seaman	2002	5
18	Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia European Neuropsychopharmacology ·S.H. Hamilton, Alan Breier, S.R. David	1998	5
19	Quantitative evaluation of astrocyte densities in schizophrenia Schizophrenia Research ·Peter Falkai, S.R. David, B. Bogerts, U. Tapernon-Franz	1991	4
20	Analysis of the QTc interval in acutely agitated patients with schizophrenia, bipolar mania, or dementia treated with intramuscular (IM) olanzapine vs. IM placebo or IM haloperidol European Neuropsychopharmacology ·S.R. David, Charles M. Beasley, Karla Alaka	2001	4

About S.R. David

S.R. David is a scholar working on Psychiatry and Mental health, Clinical Psychology, Pharmacology, Statistics and Probability and Experimental and Cognitive Psychology, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (14 papers), Electroconvulsive Therapy Studies (10 papers), Bipolar Disorder and Treatment (9 papers), Healthcare Decision-Making and Restraints (7 papers), Epilepsy research and treatment (3 papers), Treatment of Major Depression (3 papers), Statistical Methods and Bayesian Inference (2 papers) and Psychiatric care and mental health services (2 papers). The work is most often cited by research in Psychiatry and Mental health (1.2k citations), Clinical Psychology (560 citations), Biological Psychiatry (48 citations), Statistics and Probability (145 citations) and Pharmacology (196 citations). S.R. David has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Craig Mallinckrodt, W. Scott Clark, Alan Breier, Cindy C. Taylor, Karena Meehan, Mauricio Tohen, Bruce J. Kinon, Pádraig Wright, Martin Birkett and T. Jacobs. Their work appears in journals such as European Neuropsychopharmacology, Schizophrenia Research, European Psychiatry, American Journal of Psychiatry and Mathematical and Computer Modelling.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact